Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2023 Mar;38(3):433-440.
doi: 10.1111/jgh.16096. Epub 2023 Jan 23.

A double blind randomized controlled trial to assess efficacy of nutritional therapy for prevention of recurrence of hepatic encephalopathy in patients with cirrhosis

Hardik Ahuja  1 , Barjesh Chander Sharma  1 , Sanjeev Sachdeva  1 , Bhawna Mahajan  2 , Ashok Sharma  3 , Sushma Bara  1 , Siddharth Srivastava  1 , Ajay Kumar  1 , Ashok Dalal  1 , Ujjwal Sonika  1
Affiliations
Randomized Controlled Trial

A double blind randomized controlled trial to assess efficacy of nutritional therapy for prevention of recurrence of hepatic encephalopathy in patients with cirrhosis

Hardik Ahuja et al. J Gastroenterol Hepatol. 2023 Mar.

Abstract

Background and aim: Overt hepatic encephalopathy (OHE) has high risk of recurrence and is associated with poor survival. The role of nutrition therapy is well documented in cirrhosis, but its efficacy in preventing the recurrence of OHE has not been studied.

Methods: In double blind RCT, we randomly assigned 150 patients with liver cirrhosis, with history of OHE in recent past to receive nutrition therapy (group I) or no nutrition therapy (group II) and followed up for 6 months. The primary efficacy end points were occurrence of breakthrough episodes and time to breakthrough episode of OHE. Secondary end points were OHE related hospitalizations and time to hospitalization involving OHE. Other parameters included anthropometry, changes in serum cytokines (IL-1, IL-6, IL-10, and TNF-α), endotoxin and myostatin.

Results: There was significant reduction in occurrence of breakthrough episodes of OHE in group I [10 vs 36, hazard ratio 0.20; P < 0.001], OHE-related hospitalization [8 vs 24, hazard ratio 0.27; P < 0.001)]. Times to breakthrough episode of OHE and OHE-related hospitalization were longer in group I. At the end of 6 months, inflammatory and anthropometry parameters showed significant improvement in group I compared with worsening of serum albumin, anthropometric parameters, IL-6, IL-10 and TNF-α in group II. At the end of 6 months, ascites (50 vs 66, P = 0.01), gastrointestinal bleed (2 vs 11, P = 0.007), and jaundice (16 vs 41, P < 0.001) were lower in group I.

Conclusions: Treatment with nutrition therapy prevented recurrence of OHE and decreased OHE-related hospitalizations as compared with no nutrition therapy.

Keywords: cirrhosis; hepatic encephalopathy; nutrition.

PubMed Disclaimer

Comment in

References

    1. Nabi E, Thacker LR, Wade JB et al. Diagnosis of covert hepatic encephalopathy without specialized tests. Clin. Gastroenterol. Hepatol. 2014; 12: 1384-1389.
    1. Jepsen P, Ott P, Andersen PK, Sorensen HT, Vilstrup H. Clinical course of alcoholic liver cirrhosis: a Danish population-based cohort study. Hepatology 2010; 51: 1675-1682.
    1. Vilstrup H, Amodio P, Bajaj J et al. Hepatic encephalopathy in chronic liver disease: 2014 practice guidelines by the American Association for the Study of the Liver diseases and the European Association for the Study of Liver. J. Hepatol. 2014; 60: 715-735.
    1. Merli M, Giusto M, Gentili F et al. Nutritional status: its influence on the outcome of patients undergoing liver transplantation. Liver Int. 2010; 30: 208-214.
    1. European Association for the Study of the Liver. EASL Clinical Practice Guidelines on nutrition in chronic liver disease. J. Hepatol. 2019; 70: 172-193.

Publication types

LinkOut - more resources